Publicação
Assessing the market and financial potential of selfmed pill dispenser: a start-up aiming to eradicate medication non-adherence in Portugal
| Resumo: | Non-adherence to medication is a global problem that affect half of the prescription users, resulting in suboptimal therapy outcomes and premature death. The complexity of medication is one of the primary contributing factors for it. To assist with the complex medication regimen, an automatic pill dispenser, SelfMed has been created. This study focuses on studying a future start-up company, SelfMed Lda. The company will operate in the Portuguese market and aims to increase adherence to taking medication according to medical prescription by adults over the age of 60. The aim of this research is to evaluate the market and the financial viability of a project in Portugal called "SelfMed, your medicating partner," which aims to manufacture and market an automatic pill dispenser to healthcare organizations, companies in this sector of activity, and pharmacies (Business to Business). Thus, it is intended to demonstrate to what extent the implementation of the project is possible and capable of replacing the need for personalized care in older individuals for the purpose of managing the taking of medicines. The research was conducted using primary data collected through a questionnaire distributed to users and care institutions/companies in the referenced area. According to the analysis, ~36% of users and 40% of care companies are interested in obtaining SelfMed to simplify the complex medication management and prescription regimen for the end user. Considering an assessment of the 6-year financial plan, a total investment of approximately €239,000 is required to launch the project, consisting mainly of basic equipment and transport, as well as supporting buildings and infrastructure, software, among others. Based on the established assumptions, the project is commercially and financially viable, with positive results from the third year onwards and an NPV of €185,051, IRR of 23.8% and a payback period of approximately 4.47 years. |
|---|---|
| Autores principais: | Bhandari, Laxmi |
| Assunto: | Medication intake Elderly Digital solution Marketing plan Financial plan |
| Ano: | 2022 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Instituto Politécnico de Bragança |
| Idioma: | inglês |
| Origem: | Biblioteca Digital do IPB |
| Resumo: | Non-adherence to medication is a global problem that affect half of the prescription users, resulting in suboptimal therapy outcomes and premature death. The complexity of medication is one of the primary contributing factors for it. To assist with the complex medication regimen, an automatic pill dispenser, SelfMed has been created. This study focuses on studying a future start-up company, SelfMed Lda. The company will operate in the Portuguese market and aims to increase adherence to taking medication according to medical prescription by adults over the age of 60. The aim of this research is to evaluate the market and the financial viability of a project in Portugal called "SelfMed, your medicating partner," which aims to manufacture and market an automatic pill dispenser to healthcare organizations, companies in this sector of activity, and pharmacies (Business to Business). Thus, it is intended to demonstrate to what extent the implementation of the project is possible and capable of replacing the need for personalized care in older individuals for the purpose of managing the taking of medicines. The research was conducted using primary data collected through a questionnaire distributed to users and care institutions/companies in the referenced area. According to the analysis, ~36% of users and 40% of care companies are interested in obtaining SelfMed to simplify the complex medication management and prescription regimen for the end user. Considering an assessment of the 6-year financial plan, a total investment of approximately €239,000 is required to launch the project, consisting mainly of basic equipment and transport, as well as supporting buildings and infrastructure, software, among others. Based on the established assumptions, the project is commercially and financially viable, with positive results from the third year onwards and an NPV of €185,051, IRR of 23.8% and a payback period of approximately 4.47 years. |
|---|